Vericel to Participate in Multiple Upcoming Investor Conferences GlobeNewswire - Wed Feb 20, 7:29AM CST CMTX - Wed Feb 20, 7:29AM CST
Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced participation in multiple upcoming investor conferences.
Vericel to Report Fourth-Quarter 2018 Financial Results on February 26, 2019 GlobeNewswire - Tue Feb 12, 7:29AM CST CMTX - Tue Feb 12, 7:29AM CST
Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the following webcast and conference call to discuss its fourth-quarter...
Vericel to Present at the 21st Annual Needham Growth Conference GlobeNewswire - Fri Jan 11, 11:11AM CST CMTX - Fri Jan 11, 11:11AM CST
Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, president and CEO, will present the latest...
Bull or Bear: Your Investment Strategy for 2019 Sejuti Banerjea - Zacks Investment Research - Fri Jan 4, 11:02AM CST Sejuti Banerjea - ZACKS - Fri Jan 4, 11:02AM CST
Whether you're a bull or a bear, it may be a good idea to go defensive about now.
Vericel Reports Publication of Outcomes Data From 954 Burn Patients Treated With Epicel in the Journal of Burn Care and Research GlobeNewswire - Fri Jan 4, 9:00AM CST CMTX - Fri Jan 4, 9:00AM CST
Vericel Corporation (Nasdaq:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced the publication of outcomes data for 954 burn patients treated...
Zacks.com featured highlights include: Alteryx, Vericel, Mitek and Materialise Zacks Equity Research - Zacks Investment Research - Thu Jan 3, 8:39AM CST Zacks Equity Research - ZACKS - Thu Jan 3, 8:39AM CST
Zacks.com featured highlights include: Alteryx, Vericel, Mitek and Materialise
4 Stocks With Recent Price Strength to Maximize Your Gains Zacks Equity Research - Zacks Investment Research - Wed Jan 2, 7:33AM CST Zacks Equity Research - ZACKS - Wed Jan 2, 7:33AM CST
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
Has Vericel (VCEL) Outpaced Other Medical Stocks This Year? Zacks Equity Research - Zacks Investment Research - Thu Dec 27, 8:30AM CST Zacks Equity Research - ZACKS - Thu Dec 27, 8:30AM CST
Is (VCEL) Outperforming Other Medical Stocks This Year?
5 Nasdaq Composite Stocks That Braved the Index's Bloodbath Nalak Das - Zacks Investment Research - Wed Dec 26, 6:45AM CST Nalak Das - ZACKS - Wed Dec 26, 6:45AM CST
Despite a plummeting Nasdaq Composite, a few companies have survived the turbulence because of their internal strengths.
4 Healthcare Stocks That Popped More Than 100% in 2018 Sapna Bagaria - Zacks Investment Research - Wed Dec 19, 7:49AM CST Sapna Bagaria - ZACKS - Wed Dec 19, 7:49AM CST
Players in the Healthcare sector gained from aging population, expanding government business, technological investment, strong demand for its product and services and industry consolidation.
Zacks.com featured highlights include: TEGNA, Vericel, Mobile Mini and Splunk Zacks Equity Research - Zacks Investment Research - Wed Dec 19, 7:45AM CST Zacks Equity Research - ZACKS - Wed Dec 19, 7:45AM CST
Zacks.com featured highlights include: TEGNA, Vericel, Mobile Mini and Splunk
Four Biotech Stocks That Popped More Than 50% in 2018 Zacks Equity Research - ZACKS - Tue Dec 18, 7:24AM CST Zacks Equity Research - ZACKS - Tue Dec 18, 7:24AM CST
Four Biotech Stocks That Popped More Than 50% in 2018
4 Best Stocks That Flaunt Superb Earnings Acceleration Tirthankar Chakraborty - Zacks Investment Research - Tue Dec 18, 5:14AM CST Tirthankar Chakraborty - ZACKS - Tue Dec 18, 5:14AM CST
Studies show that a majority of successful stocks see acceleration in earnings before an uptick in the stock price.
Vericel (VCEL) Flat As Market Sinks: What You Should Know Zacks Equity Research - Zacks Investment Research - Fri Dec 14, 4:45PM CST Zacks Equity Research - ZACKS - Fri Dec 14, 4:45PM CST
Vericel (VCEL) closed the most recent trading day at $17.10, making no change from the previous trading session.
Has Vericel (VCEL) Outpaced Other Medical Stocks This Year? Zacks Equity Research - Zacks Investment Research - Mon Dec 10, 8:30AM CST Zacks Equity Research - ZACKS - Mon Dec 10, 8:30AM CST
Is (VCEL) Outperforming Other Medical Stocks This Year?
Small-Cap ETFs & Stocks to Outperform This Holiday Season (Revised) Sweta Killa - Zacks Investment Research - Mon Dec 3, 7:00AM CST Sweta Killa - ZACKS - Mon Dec 3, 7:00AM CST
The outperformance of the small-caps seems to hold true this year given that these pint-sized stocks are well insulated from international headwinds.
Small-Cap ETFs & Stocks to Outperform This Holiday Season (Revised) Sweta Killa - ZACKS - Mon Dec 3, 1:00AM CST Sweta Killa - ZACKS - Mon Dec 3, 1:00AM CST
The outperformance of the small-caps seems to hold true this year given that these pint-sized stocks are well insulated from international headwinds.
Zacks.com highlights: Helen of Troy, Vericel, Mobile Mini and Logitech International Zacks Equity Research - Zacks Investment Research - Fri Nov 30, 8:21AM CST Zacks Equity Research - ZACKS - Fri Nov 30, 8:21AM CST
Zacks.com highlights: Helen of Troy, Vericel, Mobile Mini and Logitech International
4 Best Stocks to Buy for Superb Earnings Acceleration Tirthankar Chakraborty - Zacks Investment Research - Thu Nov 29, 7:42AM CST Tirthankar Chakraborty - ZACKS - Thu Nov 29, 7:42AM CST
Studies have shown that a majority of successful stocks had seen acceleration in earnings before an uptick in the stock price.
Zacks.com highlights: Vericel, Mitek, Vanda Pharmaceuticals, Mosaic and Spirit Airlines Zacks Equity Research - Zacks Investment Research - Thu Nov 29, 7:05AM CST Zacks Equity Research - ZACKS - Thu Nov 29, 7:05AM CST
Zacks.com highlights: Vericel, Mitek, Vanda Pharmaceuticals, Mosaic and Spirit Airlines
